Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — A Recap of Cannabis Reform Wins in 2022

The 2022 cannabis reform has notched sizeable wins, adding three new states into adult-use cannabis legalization. NORML emphasizes how active lawmakers have been under the prohibition status quo and are looking for new policies that would build on the cannabis reform movement.

By last count, 21 states have legalized cannabis for adult use with a even more accessing medical marijuana. Voters were instrumental in repealing prohibitions placed on marijuana, thus offering relief to millions suffering from the effects of prohibition, said NORML deputy director Paul Armentano. While the focus is on legalization and reform setbacks, lawmakers have achieved some victories.

Legalization

Rhode Island, Missouri and Maryland were the new entrants to the legalization of adult-use marijuana arena. Maryland and Missouri reached that status through voting, while Rhode Island passed a state reform that was signed into law.

Expungement

California, Colorado and Illinois lawmakers approved bills for cannabis expungement or record sealing. Governor Gavin Newsom of California demanded court record sealing processes and other relief forms for individuals with verifiable cannabis convictions on record within a specified period.

Medical marijuana

An estimated 12 states agreed to pass medical marijuana reforms this year. California signed a law to prevent localities from prohibiting service delivery, thus reducing the patient access gap.  The University of Kentucky has a cannabis research center facilitating studies on the benefits and risks of cannabis.

Louisiana is allowing nurses to issue a medical marijuana recommendation and let out of state clients with specific conditions to access cannabis clinic facilities. Washington, DC, increased the limit for marijuana possession for patients, while also allowing adults of 21years and over to declare themselves as medical cannabis patients.

Utah, Virginia, Maine, Pennsylvania, South Dakota and Tennessee have also enacted reforms.

Workplace drug testing

This policy has three states enacting a reform to this effect. California banned employers from discriminating against workers whose drug tests show THC metabolites are present. Medical marijuana employment protections were recently made law in Louisiana and Washington, DC.

Equity

Anyone with a previous drug record could not be employed meaningfully in Maine. But the state repealed this to allow for ex-offenders to apply for work and not be discriminated against.

Industry and interstate trade

California governor signed a revised bill for the marijuana tax structure in order to remove barriers to gain entry into the market and cutting off the black market. Another bill allows the governor to enter into interstate marijuana commerce, awaiting a federal policy change.

These and other reforms that occurred in different jurisdictions around the country suggest that the overall cannabis market is going to keep growing, and plant-touching and nonplant-ouching enterprises such as Advanced Container Technologies Inc. (OTC: ACTX) all have a chance to tap the opportunities this growth presents.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection of vital-sign data of temperature, blood pressure, heart rate and respiratory rate. In addition, subjective evaluations related to throat burn, user experience, gastrointestinal experience and more will be conducted.

To view the full press release, visit https://cnw.fm/oo3vL

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 27 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Cannabis Products Continue to Flourish, Showcasing Potential of Cultivator Flora Growth Corp.’s (NASDAQ: FLGC) Growing International House of Brands

  • Cannabis grower and brand builder Flora Growth is a rapidly growing international supplier and supply chain developer aiming to distinguish itself in a highly competitive market
  • Following on a 604 percent YOY revenue increase for the first half of the year, Flora continues pursuing strategic acquisitions such as its recent all-stock deal for multi-national operator Franchise Global Health
  • Flora also anticipates expanding its production facilities, adding a fourth by the end of this year that will provide the company with its first pharmaceutical formula operation for the Colombian wellness market
  • The Franchise Global Health agreement is expected to give Flora a strong presence in Germany and an introduction to Europe, adding to its export pipeline to Switzerland, the Czech Republic and the United States from Colombia

Legal cannabis has become the the sixth-largest cash crop in the United States after corn, soybeans, hay, wheat and cotton (https://cnw.fm/RChLp), and voters continue to address the potentials of an expanding market for recreational marijuana (https://cnw.fm/IO2FN).

Non-recreational medicinal cannabis has been legalized in 37 states and continues to fuel a multi-billion dollar industry (https://cnw.fm/I17Vl), which is only a portion of the global market that supplies the 80 percent of the world’s population using cannabis or hemp for medical treatments. For now, international annual growth rates are more robust than the projected growth rates in the United States, according to Kiplinger (https://cnw.fm/tXctZ).

Cannabis cultivator and global distributor Flora Growth (NASDAQ: FLGC) is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena.

Much of Flora Growth’s strength lies in its licensed cultivation, extraction, and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market.

From its 247 acres of growing fields, the company’s harvests move into a production pipeline that includes a flower and derivatives production lab situated with the cultivation camp, as well as a topical, capsules and dietary supplements lab in Colombia’s capital and a third lab in the United States, where CBD ingestible, tinctures and gummies are made.

A fourth state-of-the-art lab being built in Colombia’s capital is being designed to formulate custom and proprietary pharmaceuticals that will be sold and used in Colombia. The life sciences lab is expected to open by the end of this year with eight registered pharmaceutical grade formulas that target specific ailments such as insomnia, epilepsy, and anxiety (https://cnw.fm/bbuJj).

“At Flora, we believe that cannabis will dramatically improve the wellbeing of consumers around the globe and that it will become an international trade. Our company exists today to capitalize on that opportunity,” CEO Luis Merchan stated last month in an interview about its most recent acquisition to help fuel its global ambitions — an all-stock deal for multi-national operator Franchise Global Health (https://cnw.fm/Qs3Qn).

The Franchise Global Health (“FGH”) acquisition is expected to give Flora an in-road to Europe through Germany, where FGH helped pioneer the European cannabis market and where 75 to 80 percent of European sales take place.

FGH’s German businesses operate primarily in the export pharmaceutical and medical cannabis import and distribution markets, servicing 1,200 pharmacies in Germany, according to a company news release (https://cnw.fm/6z8lD).

Notably, while Flora’s operation provides THC and CBD flower and derivatives to international markets, the company only produces CBD products within the United States because its NASDAQ listing prevents it from participating in the THC (traditional tetrahydrocannabinol cannabis) market domestically.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Canadian Medical Marijuana Companies Target Patients with Health Cover

As the marijuana market diminishes, Canadian entities are focusing on selling medical marijuana to patients whose employers provide MMJ health benefits. Alberta’s Aurora Cannabis and other market players have taken up a benefits-focused clinical strategy even as prices fall in the country’s broken-down, aggressive adult-use marijuana market.

But the uptake of medical cannabis benefit coverage is low. Prior to adult-use legalization, analysts expected the coverage would be a great area for self-insured benefits plans. That didn’t manifest as expected because few have adopted the coverage. This coverage has two types — the self-insured and the fully insured — says Mike Sullivan, an employee of Cubic Health, an employee consultancy firm.

The benefit-focused strategy seeks an avenue for higher-margin growth in this maturing market. However, cannabis entities say serving benefit-covered patients comes with high costs for education, research and customer relations.

Aurora Cannabis, which commands a 24% stake in the market, has channeled its business toward medical marijuana citing reliance on insured customers whose benefits cover MMJ. This has accounted for 80% of the company’s $17.2 million revenue in its first quarter. Those in an insured program buy more often and stay on similar medication for longer as opposed to the noninsured customers. Additionally, medical marijuana generates twice the profit of recreational marijuana in sales.

Aqualitas, a Nova Scotia cannabis producer. also said about 75% of its sales is from insured clientele. Ontario’s Entourage Health also records 90% of its revenue from insured clients bringing in $2.3 million in the recent financial quarter. Entourage absorbs the cost of consumer education, call centers and physicians, which in the process affects its margins.

Entourage Health CEO George Scorsis says the company’s margins on medical marijuana are not higher than for adult use. The profit is affected by the daily running of the business in terms of clinical work, product development, etc.

The Canadian medical cannabis market stood at $68.5 million by the third quarter of 2022 denoting that it runs into $274 million yearly. Veterans from the military are the largest beneficiaries of the benefit-covered medical marijuana project, spending $143.7 million of cannabis reimbursements in the 2022–2023 financial year.

Ned Pojskic, vice president of Green Shield Canada, the fourth-largest benefits company in the country, says prior interest in benefits coverage of medical marijuana failed to capture broad interest. Human resource leaders have been focusing on drug costs and the COVID-19 pandemic in relation to sales, among other things. Benefits expert Sullivan said after the legalization of adult-use cannabis in 2018, Canadian companies lost focus on medical marijuana. Aurora’s Martin agrees with Pojskic that extensive research could increase the benefits acceptance of medical cannabis.

As more players such as India Globalization Capital Inc. (NYSE American: IGC) go a step further and develop approved cannabis-based pharmaceuticals, the medical insurance industry is likely to move faster along the path of covering medical marijuana for policyholders.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Germany Could Trigger Domino Effect of Marijuana Legalization in Europe

While the United States and other areas spent the past two decades legalizing cannabis within their borders and launching multibillion dollar cannabis industries, Europe focused more on cannabis decriminalization. Unlike legalization, which made it possible to grow, process and sell cannabis without legal repercussions, cannabis decriminalization is simply intended to remove criminal charges from cannabis possession and use, but does not facilitate the marijuana trade.

With states such as Colorado and California bringing in billions of dollars worth of cannabis sales taxes, countries across the Atlantic have begun taking notice. In a recent move that could trigger a domino effect of cannabis legalization across the European Union, German Health Minister Karl Lauterbach announced that Germany is considering legalizing cannabis production and use, and unveiled a plan for legalization.

Germany’s marijuana policy would be similar to Canada’s, stripping marijuana of its status as a narcotic; building a state-licensed system for cultivation, production, delivery and sale; launching a federal cannabis tax; and allowing adults to purchase 20 to 30 grams of cannabis for personal use.

According to Lauterbach, the cannabis legislation may be passed by lawmakers in 2024. If Germany goes forward with this plan, it would become the first nation in the European Union to legalize marijuana. With Germany’s neighbors watching the possible evolution of its cannabis policy, we may soon see a wave of cannabis reform sweeping across the EU if Germany chooses to legalize cannabis.

It is not surprising that German lawmakers are considering legalizing cannabis as the country’s governing coalition is currently comprised of parties that are keen on reform efforts. According to the Social Democrat Party, legalizing cannabis would free up law enforcement working on cannabis cases. The Free Democrat Party believes that cannabis reform could be extremely lucrative for the country, generating more than $1 billion euros ($1.06 billion) annually in cannabis taxes. The Greens, on the other hand, see legalization as a way to curtail the illicit cannabis market by depriving it of revenue.

Cannabis is one of the most popular drugs in Germany, with Lauterbach noting that four million Germans used the substance last year. He then added that a quarter of all in the 18-24 age bracket in Germany have used cannabis.

However, the German government will only go ahead with the legislation if it is completely in line with European Union law.

If everything checks out and the legislation becomes national law, adults aged 18 and older would be able to buy up to 30 grams of cannabis from licensed stores and possibly pharmacies.

While Germany is still going through the process of ending cannabis prohibition, various jurisdictions in North America are finding avenues to avail funding to cannabis companies through entities such as REZYFi Inc. so that the industry players receive the funds they need to scale and grow their operations despite federal law, which keeps traditional banks from accepting marijuana companies as clients.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – REZYFi Inc. Tailoring Financing Packages to Meet Unique Needs of Cannabis Businesses

REZYFi seeks to fill an existing funding gap, where cannabis business operators face perpetual difficulty accessing capital in the form of loans and mortgages from Federal Deposit Insurance Corporation (“FDIC”)-insured banks and financial institutions. “REZYFi regards itself as a real estate-oriented mortgage company servicing the needs of both traditional and non-traditional consumers and businesses, but with a primary focus on the cannabis sector. The company mainly offers mortgage origination and specialized financing to licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies,” a recent article reads. “Leveraging its team’s significant experience in a wide range of real estate and financing sub-sectors, the company is able to tailor financing packages to meet the unique needs of cannabis businesses. Along with its experienced management and staff, REZYFi boasts a network of independent brokers and licensed loan officers, as well as proprietary loan processing and back-office technology powered by machine learning. The technology, in particular, shortens loan processing timeframes and reduces inefficiencies and human errors associated with manual loan processing, underwriting and servicing.”

To view the full article, visit https://cnw.fm/VOg1O

About REZYFi Inc.

REZYFi is a cannabis-focused mortgage origination and specialized financing company in the U.S. The company originates, structures and invests in first mortgage loans and alternative structured financings secured by commercial and residential real estate properties. For more information, visit the company’s website at REZYFi.com.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Policymaker Optimism for Real Estate Lending Trends Portends Blue Sky Opportunity for Mortgage Loan Facilitator REZYFi, Inc.

  • Real estate market watchers have been encouraged by recent trends in inflationary policy and lending policy analysis
  • The mid-December Consumer Price Index report and the subsequent Federal Reserve funds rate decision fell in line with expectations that inflation may have passed its peak and is beginning to decline
  • Real estate lenders expect mortgage rates to trend lower as a result of the policy news
  • Miami-based REZYFi Inc., a mortgage lender working with traditional loans and non-traditional market sectors such as the cannabis industry, has been preparing to meet a very fast-growing residential mortgage origination opportunity
  • REZYFi is working toward an IPO, having built a network of independent brokers and proprietary technology to service home owners and corporate clients with proprietary automated/machine learning technology

Housing market watchers are celebrating the Federal Reserve’s announcement Dec. 14 that it was going to raise the federal funds rate for the seventh time this year to curb inflation, recognizing that the announcement was in line with predictions that cooling inflation trends could lead to the start of a trend by policymakers to lower the amount of rate increases and thereby begin lowering mortgage rates.

After several 75 base points increases this year, December’s 50 base points decision and the companion reports of inflation-limiting successes in the Consumer Price Index (“CPI”) (https://cnw.fm/vg2h9) have led investors to speculate that central bank policymakers would pursue a less aggressive policy path in 2023. As a result, the Mortgage Bankers Association (“MBA”) is predicting that 30-year fixed mortgage rates expected to end this year at 6.7 percent will drop to 5.2 percent next year, according to a HousingWire report (https://cnw.fm/uLlgZ).

Overall mortgage application volume rose 3.2 percent during the week before the coupling of the CPI report and the Fed’s rate announcement, with applications to buy a new home rising 4 percent, and the potential for a positive rate trend is driving hopes that further housing market gains will take place next year.

“The ongoing moderation in home-price growth, along with further declines in mortgage rates, may encourage more buyers to return to the market in the coming months,” Joel Kan, an MBA economist, stated (https://cnw.fm/zPiNe).

Similar reports of potentially passing peak inflation in Europe cautiously bolster the market expectations on a global level (https://cnw.fm/P87fV).

Real estate-oriented mortgage loan origination company REZYFi has spent the past five years building its strategy to meet a very fast-growing residential mortgage origination opportunity, further encouraged by the early pandemic home sales boom and the now-developing optimism for future market improvements.

REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers while investing heavily in proprietary automated/machine learning technology to shorten loan processing timeframes and reduce inefficiencies related to loan processing, underwriting and servicing.

The company also is focusing on non-traditional lending markets such as licensed and permitted cannabis companies, as well as owners of real estate who lease to cannabis companies.

REZYFi is building toward a planned public IPO launch for its operation, and with its 100 percent-owned subsidiaries REZYFi Lending and ResMac Inc. has established licensing in 36 states with plans to expand across the entire United States.

For more information, visit the company’s website at www.REZYFi.com. 

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Report Documents Safety Risks Linked to Cash-Intensive Marijuana Businesses

The congressional marijuana banking reforms are in limbo. A report highlights one key issue that supporters argue makes legislation paramount: the fact that cash intensive marijuana dispensaries are seriously exposed to crime. While some think those entities are prone to burglary because thieves come for the product, other report that cash is the primary lure.

Marijuana markets are the target of burglaries, including some that turned violent and even fatal in 2021. In less than five months, almost 100 shops in Washington state were robbed, leading to increased calls from lawmakers to pass the Secure and Fair Enforcement (SAFE) banking act, which would allow cannabis traders access to traditional monetary institutions. The act was passed in the House, but it got stuck in the Senate. Lawmakers were discouraged to discover that SAFE was not included in the National Defense Bill.

According to some research, cash is the target in 50% of cannabis robberies, even though the product also plays a strong role. In other robberies, both money and the product are taken. There is urgency to pass the SAFE bill because this would provide relief to cannabis entrepreneurs. But there is a flaw, a report intimated: as focus to normalize depository transactions for such businesses without a proper language to address the credit card processing, cannabis firms will use cash in almost all their transactions. More needs to be done after the bill passes Congress for the robbery issue to be addressed, including allowing purchase transaction, or a means through which cash enters the system. Currently SAFE language only recognizes depository banking. Other issues include worker training and security outside of the premises.

The report recommended passing an incremental reform legislation for marijuana or the SAFE bill. Federal and state regulators need to review policies aimed at facilitating a larger adoption of epayment for marijuana stores.

States should provide funding for security to SMEs and improve employee training to emphasize deescalating tension and cooperating with robbers to avoid fatalities. The bill’s House sponsor said he was looking for an alternative reform vehicle.

Omitting the banking bill in the National Defense Authorization Act (NDAA) has been a disappointment to advocates, potentially leading to a tiff over enacting it through a different channel. Details are emerging about a SAFE Plus package that Senate majority leader Chuck Schumer is working on with bipartisan and bicameral offices. The package would be introduced and spearheaded as standalone and center on the SAFE Bill Act.

Lawmakers are also discussing including the SAFE Plus phrasing to protect users’ second amendment rights. Legalized states need to exempt users from federal limitations that bar any cannabis user from owning a gun; SAFE Plus seeks to enjoin the Gun Rights & Marijuana Act (GRAM).

Schumer, in October, said Congress was close to tabling as well as passing the cannabis banking and expungements bill, denoting progress during discussions with Republican senators. Senator Cory Booker said with the election over, Democrats who wish to enact marijuana reform must act now. Booker initially opposed taking the banking reforms before Congress but softened and became quite liberal to moving incremental legislation.

Some advocates would like to see the bill tweaked to fund minority deposit-taking institutions (MDIs) as well as community-based development financial institutions (CDFIs), which support companies being owned by minorities. They also ask for changes demanding banks work with marijuana industry to lend indiscriminately.

The Independent Community Bankers of America (ICBA), a bankers’ association, wrote to the Senate asking members to call a vote on SAFE banking soon. Soon is what the entire marijuana industry, together with related companies such as Advanced Container Technologies Inc. (OTC: ACTX), would like to see regarding the passing of cannabis banking regulations.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Veterans’ Organizations Urge Congress to Approve Medical Cannabis Research Bill

Last week, a syndicate of more than 20 veterans’ service organizations forwarded a letter to congressional leaders, urging them to approve the VA Medicinal Cannabis Research Act before the end of the current session. The organizations included Disabled American Veterans, AMVETS and Iraq and Afghanistan Veterans of America.

These veterans’ service organizations want legislators to pass the cannabis and veterans research legislation, which would make it necessary for the Department of Veterans Affairs to carry out clinical trials studying the therapeutic potential of marijuana for military veterans.

The letter states that many veterans have, for decades, requested that medicinal marijuana be prescribed as a treatment option for PTSD and other injuries sustained through services. It also states that caregivers and veterans have recounted their anecdotal experiences regarding how marijuana is effective in addressing some of the health concerns they face.

The letter then notes that the veterans’ service organizations remain committed to carrying out studies into the effectiveness of medicinal marijuana as a treatment for veterans with post-traumatic stress disorder, chronic pain and traumatic brain injuries.

Currently, marijuana remains classified as a Schedule I drug under the Controlled Substances Act. This classification makes it harder for researchers to study the drug’s effectiveness because many bureaucratic hurdles impede research.

The senate version of the legislation is being led by Senators Dan Sullivan and Jon Tester while the House version is being sponsored by Representatives Peter Meijer and Lou Correa. Correa stated in a recent interview that alternative treatment options for veterans needed to be explored, noting that federal policies that support such treatment options were needed.

Despite protests of VA officials, the bill cleared a House committee in 2021. Earlier versions of the initiative were advanced through committee in 2018 and 2020 but are yet to be enacted into law.

Meanwhile, the National Defense Authorization Act that was recently released following bicameral negotiations does not include separate language from a version that had been approved by the House. That bill would have allowed VA physicians to recommend medical marijuana to veterans living in states where the drug is legal.

However, an explanatory statement for the large-scale defense spending legislation directed the defense department to look into the potential of plant-based treatments such as marijuana and some psychedelics for service members.

Additionally, President Joseph Biden signed a broader cannabis research legislation recently. The legislation will help streamline the process for researchers to obtain and conduct research on marijuana.

This law could possibly ease the way for any research that industry players such as Flora Growth Corp. (NASDAQ: FLGC) would like to undertake on marijuana or any of its compounds.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Shares Annual General Meeting Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2022 annual meeting. The meeting of shareholders was held Dec. 15, 2022. During the meeting, shareholders considered and voted on all matters outlined in InMed’s notice of meeting and management information circular. Specifically, the election of directors was held, and shareholders approved the election of all director nominees to hold office until the next annual meeting of shareholders. Those directors included Eric Adams, Andrew Hull, Janet Grove, Bryan Baldasare, and Nicole Lemerond.

To view the full press release, visit https://cnw.fm/cv24L

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.